MedChemExpress LLC Email Format
Biotechnology ResearchNew Jersey, United States51-200 Employees
MedChemExpress LLC operates in the biotechnology research industry as a global supplier of life science reagents. Its catalog includes active molecules such as inhibitors, compound libraries, recombinant proteins, and antibodies, supporting both basic research and drug development. The company provides an end-to-end service framework that includes data analysis, bioactivity evaluation, technical consultation, and after-sales support, serving more than 15,000 research institutions worldwide. Headquartered in Monmouth Junction, New Jersey, MedChemExpress operates multiple R&D, production, and logistics centers around the world, reflecting a mid-sized, globally oriented organization. In March 2023, it announced the launch of Geptanolimab, a humanized PD-1-targeting monoclonal antibody.